Table 2. A summary of the different approaches directed against myocilin for treating myocilin associated glaucoma.
Method | Mode of Action | References |
---|---|---|
Treatment with chemical chaperones |
Relieve ER stress by promoting folding of mutant myocilin |
Yam et al. 2007 [146], Burns et al. 2016 [145], Zode et al. 2011 [147], Zode et al. 2012 [148] |
CRISPR-Cas9 mediated gene editing |
Cutting the expression of mutant myocilin |
Jain et al. 2017 [76] |
Inhibiting myocilin aggregation |
Small molecules promoting stability and preventing myocilin aggregation |
Orwig et al.. 2014 [149] |
Inhibition of grp94-myocilin interaction | Promoting clearance of mutant myocilin via autophagy | Stothert et al. 2014 [114], Crowley et al. 2016 [115], Stothert et al. 2017 [117], Huard et al. 2018 [116], |